Hypertension among 1000 patients with type 2 diabetes attending a national diabetes center in Jordan

Fayzeh M Mubarak, Erika S Froelicher, Hashem Y Jaddou, Kamel M Ajlouni, Fayzeh M Mubarak, Erika S Froelicher, Hashem Y Jaddou, Kamel M Ajlouni

Abstract

Background and objectives: In Jordan, there is a paucity of research on hypertension and its risk factors among patients with type 2 diabetes mellitus. This study was designed to assess the prevalence of hypertension, risk factors, and the level of awareness and control of hypertension among outpatients with type 2 diabetes.

Subjects and methods: A cross-sectional study was carried out on a sample of 1000 patients with type 2 diabetes who were attending the National Center for Diabetes, Endocrine and Genetic Diseases for follow-up during the period of June to December 2006. Data were collected from medical records and through a structured interview questionnaire. Logistic regression analysis was used to assess the independent effect of variables on hypertension.

Results: The prevalence of hypertension (BP >130/80 or on medication for high blood pressure) was 72.4% (70.9% of males and 73.9% of females). The logistic regression indicated that hypertension was positively associated with age (P=.001), body mass index (P=.001), and duration of diabetes (P=.001). About one-half of patients who were aware of having hypertension failed to keep their blood pressure under control.

Conclusion: Hypertension is a common co-morbidity among diabetic patients. Despite a high rate of awareness of hypertension among study subjects (93%), hypertension was not controlled to the recommended levels of blood pressure in about one-half (50.4%) of patients.

References

    1. Genuth S. A case for blood glucose control. Adv Intern Med. 1995;40:573–623.
    1. Libby P, Nathan DM, Abraham K, Brunzell JD. Report of the National Heart, Lung and Blood Institute: National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of DM. Circulation. 2005;111:3489–3493.
    1. Cohen AM, Marom L. Diabetes and accompanying obesity, HTN, and ECG abnormalities in Yemenite Jews 40 years after immigration to Israel. Diabetes Res. 1993;23:65–74.
    1. Satman I, Yilmaz T. Population-based study of diabetes and risk characteristics in Turkey. Diabetes Care. 2002;25:1551–1556.
    1. Tseng CH. Higher risk of hypertension in indigenous type 2 diabetic patients in Taiwan. J Hypertens. 2006 Sep;24(9):1817–21.
    1. Baskar V, Kamalakannan D, Holland MR, Singh BM. The prevalence of hypertension and utilization of antihypertensive therapy in a district Diabetes Population. Diabetes Care. 2002;25:2107–2108.
    1. Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study. Nutr Metab Cardiovasc Dis. 2005;15:204–211.
    1. del Cañizo-Gómez FJ, Moreira-Andrés MN. Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines? Diabetes Res Clin Pract. 2004;65:125–133.
    1. Baskar V, Kamalakannan D, Holland MR, Singh BM. Does ethnic origin have an independent impact on hypertension and diabetic complications? Diabetes Obes Metabolism. 2006;8:214–219.
    1. Fong DS, Aiello LP, Ferris FL, 3rd, Klein R. Diabetic retinopathy. Diabetes Care. 2004;27:2540–2553.
    1. Tesfaye S, Chaturvedi N, Eaton SE, Ward JD, Manes C, Ionescu-Tirgoviste C, Witte DR, Fuller JH. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352:341–350.
    1. Sowers JR, Williams M, Epstein M, Bakris G. Hypertension in patients with diabetes: strategies for drug therapy to reduce complications. Postgrad Med. 2000;107:47–54.
    1. Schutta MH. Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions. J Cardiometab Syndr. 2007;2:124–130.
    1. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K. Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: the DECODA study. Eur J Cardiovasc Prev Rehabil. 2006;13:555–561.
    1. Tenenbaum A, Fisman EZ, Boyko V, Goldbourt U, Auerbach I, Shemesh J, Shotan A, Reicher-Reiss H, Behar S, Motro M. Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris. Am J Cardiol. 1999;84:294–298.
    1. Jaddou H, Bateihah MA, Ajlouni KM. Prevalence and associated factors of hypertension results from a three community based survey Jordan. J Hum Hyperten. 1996;10:815–821.
    1. Jaddou H, Bateihah MA, Ajlouni KM. Prevalence, awareness and management of hypertension in recently urbanized community, Eastern Jordan. J Hum Hypertens. 2000;14:447–501.
    1. Jaddou H, Bateihah MA, Ajlouni K. Epidemiology and management of hypertension among Bedouins Northern Jordan. Saudi Med J. 2003;24(5):472–476.
    1. JNC 7: Complete Report. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003;42:1206.
    1. Al-Moosa S, Allin S, Jemiai N, Al-Lawati J, Mossialos E. Diabetes and urbanization in the Omani population: an analysis of national survey data. Popul Health Metr. 2006;24:4–5.
    1. Akbar D, Ahmed MM, Algambi AA. Cardiovascular risk factors in Saudi and non-Saudi diabetics. Saudi Med J. 2003;24:686–87.
    1. Al-Mahroos F, Al-Roomi K, McKeigue PM. Relation of high blood pressure to glucose intolerance, plasma lipids and educational status in an Arabian Gulf population. Int J Epidemiol. 2000;29:71–76.
    1. Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. UK prospective diabetes study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Diabetes Care. 1997;40:1435–1441.
    1. Cowie CC, Harris MI. Physical and metabolic characteristics of persons with diabetes. In: Harris MI, editor. Diabetes in America. 2nd ed. Bethesda, Md: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Disease; 1995. pp. 117–164. NIH publication 95–1468.
    1. Sprafka JM, Bender AP, Jagger HG. Prevalence of hypertension and associated risk factors among diabetic individuals: the three-city study. Am J Clin Nutr. 2000;63:423–425.
    1. Hypertension in Diabetic Study (HDS): prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens. 1993;11:309–317.
    1. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 DM: the relation of obesity and age of onset. Diabetes Care. 2001:522–152.
    1. Tsai AC, Liou JC, Chang MC. Interview to study the determinants of hypertension in older adults in Taiwan: a population based cross-sectional survey. Asia Pac J Clin Nutr. 2007;16:338–45.
    1. McCaul KD, Kockemeyer JR, Johnson RJ, Zetocha K, et al. Motivation to quit smoking. Addict Behav. 2006;31:42–56.
    1. Hilbernik SR, Jacobs JE, Schlosser M, Grol RP, de Vries H. Characteristics of patients with COPD in three motivational stages related to smoking cessation. Patient Educ Couns. 2006;61:449–57.
    1. Rundmo T, Smedslund G, Gotestam KG. Motivation for smoking cessation among the Norwegian public. Addict Behav. 1997;22:377–86.
    1. Geiss LS, Rolka DB. Elevated blood pressure among US adult with diabetes,1988–1994. Am J Prev Med. 2002;22:42–48.
    1. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors of vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335–42.
    1. Rudd P, Houston Miller N, et al. Nurse management for hypertension: a systems approach. Am J Hypertens. 2004;17:921–927.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する